Strength
5 mg/1
Manufacturer
Astellas Pharma US, Inc.NDC
00469068773
Classification
Brand
Dosage Form
CAPSULE, COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
1/13/2025
Active Ingredients
TACROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA204096On Market Since
7/19/2013
Pharmacological Classes
Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
PROGRAF 0.5 MG CAPSULE
Brand
00469060773•Astellas Pharma US, Inc.
$3.6717
per EA
SANDIMMUNE 25 MG CAPSULE
Brand
00078024015•Novartis Pharmaceuticals Corporation
$4.3773
per EA
PROGRAF 0.2 MG GRANULE PACKET
Brand
00469123050•Astellas Pharma US, Inc.
$5.0047
per EA
ENVARSUS XR 1 MG TABLET
Brand
68992301001•Veloxis Pharmaceuticals, Inc
$6.1904
per EA
ENVARSUS XR 1 MG TABLET
Brand
68992301003•Veloxis Pharmaceuticals, Inc
$6.1904
per EA
PROGRAF 1 MG CAPSULE
Brand
00469061773•Astellas Pharma US, Inc.
$7.3508
per EA
PROGRAF 1 MG GRANULE PACKET
Brand
00469133050•Astellas Pharma US, Inc.
$7.4714
per EA
RESTASIS 0.05% EYE EMULSION
Brand
00023916330•Allergan, Inc.
$10.3144
per EA
RESTASIS 0.05% EYE EMULSION
Brand
00023916360•Allergan, Inc.
$10.3190
per EA